Off Patent
August 2026

Nuedexta

dextromethorphan hydrobromide and quinidine sulfate

Otsuka America Pharmaceutical Inc

Capsule (oral) · NDA 021879

Last listed protection ended
August 13, 2026

The FDA listed 1 patent for Nuedexta, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 7,659,282
    Claims a use (U-1093)